Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.
Already Have An Account? Log in Now
Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes — 2025
abstract
This abstract is available on the publisher's site.
Access this abstract nowThe American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Additional Info
Disclosure statements are available on the authors' profiles:
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025
Diabetes Care 2025 Jan 01;48(Supplement_1)S181-S206, American Diabetes Association Professional Practice CommitteeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This segment from the American Diabetes Association's annually updated Standard of Care in Diabetes focuses on the pharmacological management of individuals with type 2 diabetes. It includes some modest modifications of earlier guidelines, with figures that are more streamlined and easier to follow. It should be at least perused by anyone involved in the clinical care of patients with diabetes.